1 |
Ragnhildstveit A, Kaiyo M, Snyder MB, Jackson LK, Lopez A, Mayo C, Miranda AC, August RJ, Seli P, Robison R, Averill LA. Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report. Front Psychiatry 2023;14:1051542. [PMID: 36846226 DOI: 10.3389/fpsyt.2023.1051542] [Reference Citation Analysis]
|
2 |
Clouse G, Penman S, Hadjiargyrou M, Komatsu DE, Thanos PK. Examining the role of cannabinoids on osteoporosis: a review. Arch Osteoporos 2022;17:146. [PMID: 36401719 DOI: 10.1007/s11657-022-01190-x] [Reference Citation Analysis]
|
3 |
Burnett GM, Gorelick DA, Hill KP. Policy Ahead of the Science: Medical Cannabis Laws Versus Scientific Evidence. Psychiatr Clin North Am 2022;45:347-73. [PMID: 36055728 DOI: 10.1016/j.psc.2022.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Bedard-gilligan M, Lehinger E, Cornell-maier S, Holloway A, Zoellner L. Effects of Cannabis on PTSD Recovery: Review of the Literature and Clinical Insights. Curr Addict Rep. [DOI: 10.1007/s40429-022-00414-x] [Reference Citation Analysis]
|
5 |
Khoury M, Cohen I, Bar-sela G. “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics 2022;14:389. [DOI: 10.3390/pharmaceutics14020389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
|
6 |
Nacasch N, Avni C, Toren P. Medical cannabis for treatment-resistant combat PTSD. Front Psychiatry 2022;13:1014630. [PMID: 36741572 DOI: 10.3389/fpsyt.2022.1014630] [Reference Citation Analysis]
|
7 |
Incze MA, Kelley AT, Singer PM. Heterogeneous State Cannabis Policies: Potential Implications for Patients and Health Care Professionals. JAMA 2021;326:2363-4. [PMID: 34797377 DOI: 10.1001/jama.2021.21182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|